Covid 19 : 3 Types Of Ventilators Developed By ISRO

Three types of ventilators has erupted by Indian Space Research Organisation to convey the technology for clinical uses where the country conflicts with the second wave of COVID-19 pandemic.

The ventilators are based on automatic condensing of  an AMBU (Artificial Manual Breathing unit) bag. This ventilator is very reasonable and can be transferable too. This low cost ventilator is called  ‘PRANA’ (“Programmable Respiratory Assistance for the Needy Aid’).

The ventilator is manufactured with a trailblazing control system that includes airway pressure sensor, flow sensor, oxygen sensor, servo actuator as well as exhalation and PEEP (Positive End Expiratory Pressure) control valves.

There is a screen panel which is for the technicians to set the ventilation mode and fix the required parameters and they can observe various parameters like pressure, flow, tidal volume and oxygen concentration on the same screen. A craved rate which is assigned by the clinicians on the ventilator will  deliver the required flow of oxygen-air mixture to the patient’s lungs.

An external battery for backup is affixed with the ventilator in order to overcome the power failure issues.

“ISRO said PRANA supports both invasive and non- invasive ventilation modes and is capable of giving mandatory breaths (controlled by ventilator) as well as spontaneous breaths (controlled by the patient).  A robust algorithm for controlled and safe ventilation of the patient is implemented which raises alarm and opens safety valves to prevent barotrauma, asphyxia and apnoea during the ventilation.”

In case if there will be any illegitimate disconnection of the hose or sensors an alarm which is fixed with ventilator will alert the situation.

“The prototype of the three ventilators developed at Thiruvananthapuram-based Vikram Sarabhai Space Centre (VSSC), a major space research centre of ISRO, has undergone in-house test & evaluation and meets various specifications. ISRO said it intends to transfer the technology of these three ventilators toPSUs/ industries/ start-ups having good track record in manufacture of critical medical/ electronic equipment manufacturing.”

ISRO summons the entrepreneurs to accede their interest on or before June 15.

Study Conducting By ICMR To Scrutinize The Virtue Of Covishield And Covaxin In Preventing Covid-19

Since the innovation of AstraZeneca’s Covishield and Bharat Biotech’s Covaxin in the country, the Indian Council of Medical Research (ICMR) will appraise a  study  from next week to scrutinize the potency of these vaccines in preclude the concatenation of  Covid into a critical form.

As reported by senior scientist Dr Tarun Bhatnagar  at ICMR’s National Institute of Epidemiology (NIE) in Chennai revealed that, approaching 4,000 folks  the people exceeds  the age of 45 years who have taken each of  two doses either of  two vaccines will be criticized.

“As a part of the study we will take people who are COVID-19 positive and hospitalised and compare their vaccination status with those who have tested Covid negative,” Bhatnagar told PTI. The aim is to assess how effective vaccination is in preventing progression of the disease into a severe form,” he said.

Up to the present time around 20 crore  amassed vaccine doses has disbursed  in the country  so far.

The Central Government is impelling people to get vaccinated by perpetuating that the vaccine will not fortify one from dwindle the corona virus infection but by inoculating the two doses of the vaccine it will prohibits the concatenation to a extreme stage and will bring down the fatality rate.

The central authorities has been pressurizing about the necessity of wearing a face mask and adhesion to covid protocols.

At present India is using 3 vaccines against this pandemic, which includes Covishield, Covaxin , and Sputnik. Among this covishield is  manufactured by the Pune-based Serum Institute and Covaxin of Bharat Biotech in Hyderabad. Finally the Russian Sputnik V needs the approval from Drug Controller General of India (DCGI) for Emergency Use Authorization and is hardly used in private hospitals so far.

This first of its kind study is expected to be undertaken from next week, said Dr Tarun Bhatnagar, senior ICMR scientist.

Before Sharing An Article On Facebook, Users Are Advised To Read It

On Monday, Facebook announced that it is testing a new feature that will ask users to open and read an article before posting it on the social media site.

According to the company, people in the test will soon see a prompt warning them that sharing an article without reading it can cause them to miss “key information.” They’ll be given the choice of either opening the news article or continuing to share.

“We’re testing a way to promote more informed sharing of news articles. If you share a news article link you haven’t opened, we’ll show a prompt encouraging you to open it and read it, before sharing it with others,” Facebook said in a tweet from its official Newsroom account.

According to The Verge, which cites a company spokesperson, the test will be rolled out to 6% of Android users worldwide. The change is intended to reduce the spread of false information on its website.

The pop-up message will alert users that if they don’t open the post, they risk missing “important facts.” “Demotions for content on Facebook and Instagram that our systems predict could be disinformation, including debunked statements about voting,” according to Facebook.

The new functionality is modeled after a similar initiative launched by Twitter last year for similar reasons.

Facebook and Twitter have been working to fight disinformation on their platforms about a variety of subjects, including the current COVID-19 pandemic and misleading allegations of election fraud in 2020.

COVID 19: Nitrogen Plants Converts Into Oxygen Generators By IIT Bombay

We all know that our world is facing a life threatening disease called COVID 19 which is also known as Corona virus a global pandemic.

This virus cause severe acute respiratory syndrome(SARS) which leads to death. More than million cases has been confirmed. Due to this SARS  oxygen availability is dropping in some countries. In-order to overcome this threatening issue Indian Institute of Technology – Bombay (IIT –B) has come to light with a creative idea of converting Nitrogen generators to Oxygen generators.

This process of conversion is reckoned on a simple technology of permuting a pressure swing adsorption (PSA) nitrogen unit into a PSA oxygen unit.

After the primary tests they promised that the production of oxygen can be attained at 3.5atmospheric pressure with the sterility of 93% to 96%.

This pure gaseous form of oxygen can be used for COVID 19 related requirements. During this COVID 19 pandemic the scarcity of medical oxygen becomes a great threat for our country. The patients are grappling to get proper treatment due to lack of oxygen availability.

The pilot project was a joint effort between IIT Bombay, Tata Consultancy  Engineers  and  Spantech Engineers Mumbai. On the study about this oxygen crisis these three firms signed a Memo of Understanding to conclude about this project.

However to perform this  conversion of existing nitrogen plants  to oxygen convertors it will almost take four days which is less time compared to setup a new oxygen plant.

“It [conversion of nitrogen unit into an oxygen unit] has been done by fine-tuning the existing nitrogen plant set-up and changing the molecular sieves from carbon to zeolite,” the statement said quoting prof. Milind Atrey, dean (R&D), IITB, who led the project.

On 29th may 2021, IIT –B was declared about the proposal of converting nitrogen plants to oxygen generators. This solution of oxygen scarcity will helps to provide oxygen to the hospitals.

Truecaller Launched COVID Hospital Directory To Help Users

For Indian people seeking assistance during the pandemic, Truecaller has introduced a new COVID Hospital Directory. The directory is based on official government databases and contains the phone numbers and addresses of designated COVID-19 hospitals from various states throughout the world.

Truecaller claims that the data for the new feature came from official government databases. The directory is integrated into the software, and users can easily access it from the menu or dialer.

“We wanted to quickly introduce a simple directory of important numbers for Covid-related services. We have started with this hospital list and we’re working to add more verified sources soon,“ said Rishit Jhunjhunwala, MD India, Truecaller.

These hospitals are located in the United States and are based on official government databases. There is a search button that will help you find the details you need quickly. It is necessary to remember that this does not guarantee the availability of hospital beds.

The company also promises to update the database on a daily basis to ensure that as many hospital phone numbers as possible are available throughout India. On Android devices, users will need to update the app from the Google Play Store to see the functionality. As of now, the feature is only available on Android smartphones.

Twitter, for example, is releasing an advanced search feature that will assist users in finding specific information. Using the advanced search function, they can narrow down their search to a specific location, hashtags, and the date the tweet was released. You can learn more about how to use the function by clicking here.

Paytm & CRED To Tackle Oxygen Shortage From COVID-19 Crisis

Paytm has launched a fundraising drive to combat the oxygen shortage in India caused by the second wave of the coronavirus.

Paytm announced on Monday, April 26th, that as part of its ‘Oxygen for India’ project, it intends to collect Rs 10 crore and import 3,000 oxygen concentrators for government and private hospitals, COVID-19 treatment centers, NGOs, and resident welfare associations.

“All the contributions made through Paytm will be directly transferred to Paytm Foundation. Paytm Foundation will buy oxygen concentrators and distribute them to the needy,” the company wrote on its FAQ page.

The campaign, dubbed “Oxygen for India,” aims to support people who are in desperate need of oxygen. CRED, a fintech company, is also attempting to assist with oxygen supplies, partnering with healthcare crowdfunding platform Milaap to acquire and distribute oxygen concentrators across the world.

According to the FAQ website, contributions to the Oxygen for India initiative are not tax deductible, though the company has agreed to provide donation receipts within a few days.

However, unlike Paytm, CRED has not provided any details on how much amount it is planning to raise through the CRED coins it will receive from its users. The company is also showing the contributors the amount of oxygen that it would be able to distribute through the oxygen concentrators it will source, which means it’s not entirely clear how much of an impact your donation would make.

COVID-19 Vaccine Registration to Go Live in India for People Aged Above 18 Years From Today

COVID-19 vaccine registration in India for people aged between 18 and 44 years will go live from 4pm Wednesday, April 28.

This will be the third step of India’s vaccination campaign, which will broaden the current vaccination requirements to include people aged 45 and up. COVID-19 vaccination registration is required, and qualified individuals must have a valid Indian identification evidence, such as an Aadhaar card or a PAN card. India recently registered over 350,000 cases in a single day, the world’s highest total.

The government has made it mandatory for people aged 18 to 44 to register on the CoWIN portal and schedule a coronavirus vaccination appointment, stating that walk-ins would not be permitted at first to prevent “chaos” at immunisation centers until the inoculation campaign ramps up significantly.

Covaxin, produced by Hyderabad-based Bharat Biotech, and Covishield, developed by Oxford-AstraZeneca and manufactured by the Serum Institute of India, are the two COVID-19 vaccines currently being used in the vaccination campaign (SII).

Covishield, manufactured by the Serum Institute of India, will cost states Rs 400 per dose and private hospitals Rs 600 per dose, while Bharat Biotech’s Covaxi will cost states Rs 600 per dose and private hospitals Rs 1,200 per dose.

But don’t get your hopes up too high; while India has vaccinated a large number of people, we still have an absurdly large population, and the new push would simply increase the number of people who will be vaccinated.